Latest Financial Position News

Sierra Nevada Gold (ASX: SNX) advances its As Safra copper-gold project in Saudi Arabia by establishing a local subsidiary and preparing for imminent drilling after securing exploration licences.

Green360 Technologies has kicked off commercial production of its low-carbon Eco-Clay cement alternative through a capital-light tolling agreement with Calix, while securing federal grant funding and a $4.5 million placement to fuel growth.

Saturn Metals has pressed forward with its Apollo Hill Gold Project, appointing Ausenco for the Definitive Feasibility Study and uncovering significant high-grade gold in the emerging Titan Zone, underpinning resource growth potential.

OpenLearning accelerated its SaaS annual recurring revenue by 35% year-on-year to $3.192 million in Q1 FY26, propelled by larger multi-year LMS contracts and ongoing AI platform enhancements.

DXN Limited posted a 47.5% revenue increase to $3.7 million in Q3 FY26, buoyed by a surge in modular data centre projects and a growing pipeline of 891 identified contracts. The company advanced its Asia-Pacific footprint through a JV in Indonesia and a Malaysian manufacturing push, while securing a $5.3 million Cable Landing Station contract in Latin America.

Minerals Exploration Limited (ASX/NZX: MEX) has revealed wide gold mineralisation from its maiden drilling at the Scotia Prospect, while ongoing drilling at Jubilee confirms deeper structures. High-grade assays at Invincible set the stage for maiden drilling there.

Green & Gold Minerals completed the Herberton Conductor Metals Project acquisition, unveiling high-grade copper, silver, indium, and rare earth discoveries while maintaining a strong cash position for 2026 exploration.

Asara Resources has reported robust drilling results at its flagship Kada Gold Project in Guinea, confirming extensions to mineralisation and expanding the resource footprint. The company is also progressing regional exploration and advancing a key acquisition, maintaining a solid cash position to fund ongoing work.

Artrya has fully integrated its Salix platform at Tanner Health, is preparing two more US sites for launch, and is finalising FDA submission for its Coronary Flow module, backed by a strong cash position of $76.6 million.

Delorean Corporation reported solid progress in Q3 FY2026, including a positive Final Investment Decision for its NSW1 Horsley Park bioenergy facility backed by $30.5 million in grants, alongside ongoing construction at its flagship SA1 Salisbury project.

Electro Optic Systems (ASX: EOS) reported a 13% increase in contract backlog to A$518 million in Q1 2026, driven by multiple major defence orders and the opening of a new Singapore facility. The company’s cash position remains strong despite a $4 million ASIC penalty.

Microba Life Sciences reported a 99% year-on-year surge in core testing revenue for Q3 FY26, propelled by strong test volume growth and new clinic contracts in Australia and the UK. The company is advancing a major product release and negotiating a significant corporate transaction to bolster its financial position.